<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Nonsteroidal antiinflammatory drug (NSAID) poisoning</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Nonsteroidal antiinflammatory drug (NSAID) poisoning</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Nonsteroidal antiinflammatory drug (NSAID) poisoning</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Mark K Su, MD, MPH</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Arun Nagdev, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Robert G Hendrickson, MD, FACMT, FAACT</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michael Ganetsky, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Nov 15, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Millions of people worldwide take nonsteroidal antiinflammatory drugs (NSAIDs) on a regular basis to treat pain and inflammation. Patients with an acute overdose of NSAIDs often present to emergency departments and represent a sizable percentage of cases reported to regional poison control centers [<a href="#rid1">1</a>]. As aging populations increasingly rely on NSAIDs, chronic toxicity and acute poisonings have become more commonplace. Given the relative frequency of toxic NSAID exposures, emergency and primary care clinicians need to understand the diagnosis and management of this poisoning.</p><p>Acute NSAID poisoning is reviewed here. A summary table to facilitate emergent management is provided (<a class="graphic graphic_table graphicRef59428" href="/d/graphic/59428.html" rel="external">table 1</a>). A general approach to suspected drug intoxication and discussions of chronic NSAID toxicity are provided elsewhere. </p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/324.html" rel="external">"General approach to drug poisoning in adults"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/7991.html" rel="external">"Nonselective NSAIDs: Overview of adverse effects"</a>.)</p><p></p><p class="headingAnchor" id="H2"><span class="h1">PHARMACOLOGY</span><span class="headingEndMark"> — </span>NSAIDs are competitive inhibitors of the enzyme cyclooxygenase (COX) (<a class="graphic graphic_figure graphicRef76922" href="/d/graphic/76922.html" rel="external">figure 1</a>). NSAIDs prevent COX-mediated production of prostaglandins and thromboxanes but not leukotrienes and other eicosanoids. (See  <a class="medical medical_review" href="/d/html/7989.html" rel="external">"NSAIDs (including aspirin): Pharmacology and mechanism of action"</a>.)</p><p>There are two COX isoforms, COX-1 and COX-2. The constitutive enzyme, COX-1, is expressed in most tissues and enables regulation of basal cellular homeostasis (platelet function, gastric mucosal integrity, and regulation of renal blood flow). The activity of the inducible COX-2 isoenzyme increases in inflammatory and pain states [<a href="#rid2">2</a>].</p><p>Numerous animal and human studies have demonstrated the role of COX-1 in inflammation [<a href="#rid3">3,4</a>]. In general, all NSAIDs inhibit both isoforms, with most adverse reactions believed to be attributable to COX-1 inhibition. The development of newer COX-2 selective NSAIDs arose from the desire to maintain therapeutic antiinflammatory function, while decreasing the rates of adverse drug effects, most notably gastrointestinal and renal toxicity. (See  <a class="medical medical_review" href="/d/html/7991.html" rel="external">"Nonselective NSAIDs: Overview of adverse effects"</a>.)</p><p class="headingAnchor" id="H3"><span class="h1">KINETICS</span><span class="headingEndMark"> — </span>Oral absorption of NSAIDs approaches 100 percent and peak serum levels usually occur within one to two hours. Large toxic ingestions or concomitant food consumption can delay peak levels up to three to four hours. NSAIDs are weak acids that are extensively (up to 99 percent) protein bound, with a small volume of distribution (0.1 to 0.2 L/kg). Diseases causing low protein levels or large NSAID ingestions can decrease plasma protein binding, resulting in an increased volume of distribution and greater penetration into body tissues, including the central nervous system. </p><p>Most NSAIDs are metabolized by hepatic biotransformation with urinary excretion. The elimination half-life is usually less than 8 hours, but it ranges from 1 to 50 hours depending on the specific class and initial dose [<a href="#rid5">5</a>]. The half-lives of some common NSAIDs are as follows:</p><p class="bulletIndent1"><span class="glyph">●</span>Short half-life (&lt;8 hours): <a class="drug drug_general" data-topicid="8547" href="/d/drug information/8547.html" rel="external">ibuprofen</a>, <a class="drug drug_general" data-topicid="8559" href="/d/drug information/8559.html" rel="external">indomethacin</a>, <a class="drug drug_general" data-topicid="8591" href="/d/drug information/8591.html" rel="external">ketorolac</a>, <a class="drug drug_general" data-topicid="9348" href="/d/drug information/9348.html" rel="external">diclofenac</a></p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Long half-life (&gt;8 hours): <a class="drug drug_general" data-topicid="9682" href="/d/drug information/9682.html" rel="external">naproxen</a> (9 to 20 hours), <a class="drug drug_general" data-topicid="9725" href="/d/drug information/9725.html" rel="external">oxaprozin</a> (25 to 50 hours), <a class="drug drug_general" data-topicid="9781" href="/d/drug information/9781.html" rel="external">piroxicam</a> (30 to 86 hours), phenylbutazone (50 to 100 hours)</p><p></p><p class="headingAnchor" id="H4"><span class="h1">HISTORY AND PHYSICAL EXAMINATION</span><span class="headingEndMark"> — </span>Important historical information includes the name of the NSAID ingested, the amount ingested, the time of ingestion, and the presence of coingestants. Nausea, vomiting, and non-specific neurologic findings such as dizziness may occur. Patients should be specifically questioned about their use of <a class="drug drug_general" data-topicid="9242" href="/d/drug information/9242.html" rel="external">acetaminophen</a> and <a class="drug drug_general" data-topicid="8907" href="/d/drug information/8907.html" rel="external">aspirin</a>, as these are commonly mistaken for NSAIDs and can produce significant toxicity.</p><p>The physical examination in NSAID-poisoned patients is usually unremarkable or nonspecific. Severe poisoning may produce an acute alteration in mental status.</p><p class="headingAnchor" id="H8"><span class="h1">CLINICAL ASPECTS OF ACUTE TOXICITY</span></p><p class="headingAnchor" id="H9"><span class="h2">General</span><span class="headingEndMark"> — </span>The clinical manifestations of acute NSAID overdose tend to be minimal. In a review of over 5000 NSAID overdoses, the most common signs and symptoms were nausea, vomiting, drowsiness, blurred vision, and dizziness [<a href="#rid6">6</a>]. Less than 0.5 percent of these patients experienced severe harm (eg, kidney injury); most required no medical intervention. </p><p>In general, ingestions of less than 100 mg/kg of most NSAIDs (except <a class="drug drug_general" data-topicid="9601" href="/d/drug information/9601.html" rel="external">mefenamic acid</a> and phenylbutazone) are unlikely to cause any significant toxicity. Massive overdoses that produce severe clinical toxicity are seen with ingestions greater than approximately 400 mg/kg (lean body weight) [<a href="#rid7">7</a>]. Hypothermia may develop following a large overdose, and has been reported in a child with a therapeutic dose [<a href="#rid8">8,9</a>].   </p><p class="headingAnchor" id="H10"><span class="h2">Acid base abnormalities</span><span class="headingEndMark"> — </span>An increased anion gap metabolic acidosis may be seen after large ingestions of NSAIDs, particularly <a class="drug drug_general" data-topicid="8547" href="/d/drug information/8547.html" rel="external">ibuprofen</a>, <a class="drug drug_general" data-topicid="9682" href="/d/drug information/9682.html" rel="external">naproxen</a>, and phenylbutazone (a veterinary NSAID occasionally ingested by humans). This acidosis may represent a combination of lactic acidosis (from cellular hypoxia or seizures) and weakly acidic NSAID metabolites. Cardiac dysrhythmias and electrolyte abnormalities are thought to be due to the severe anion gap metabolic (lactic) acidosis resulting from massive NSAID ingestion [<a href="#rid8">8,10-12</a>].<strong> </strong></p><p class="headingAnchor" id="H11"><span class="h2">Acute kidney injury</span><span class="headingEndMark"> — </span>Acute kidney injury and renal papillary necrosis are reported but rare in NSAID overdose. Most commonly, these pathologic processes occur in patients with decreased effective arterial volume (heart failure, cirrhosis, protracted hypovolemia), age-related underlying renal dysfunction, or massive overdose.</p><p>Patients with NSAID-induced acute kidney injury usually present with evidence of decreasing renal function (increased serum creatinine, hyperkalemia, decreased urine volume, or weight gain). (See  <a class="medical medical_review" href="/d/html/7230.html" rel="external">"NSAIDs: Acute kidney injury"</a>.)</p><p>The diagnosis of acute renal papillary necrosis may be more difficult. Patients classically present with gross hematuria and renal colic, secondary to ureteral passage of sluffed ischemic renal tissue. To confirm the diagnosis, the clinician must inquire specifically about a recent large ingestion of NSAIDs. (See  <a class="medical medical_review" href="/d/html/7175.html" rel="external">"Clinical manifestations and diagnosis of analgesic nephropathy"</a>.)</p><p>NSAID-induced renal injury likely results from inhibition of vasodilatory prostaglandins. Prostaglandin inhibition leads to vasoconstriction and decreased renal perfusion. Discontinuation of NSAID therapy usually reverses the renal insult [<a href="#rid13">13-17</a>]. </p><p class="headingAnchor" id="H14820553"><span class="h2">Cardiovascular toxicity</span><span class="headingEndMark"> — </span>Hypotension and cardiovascular collapse have been reported following massive <a class="drug drug_general" data-topicid="8547" href="/d/drug information/8547.html" rel="external">ibuprofen</a> overdose [<a href="#rid8">8</a>]. In one case, a 14-year-old male with an intentional overdose of approximately 50 g of ibuprofen developed refractory hypotension, in addition to gastrointestinal bleeding and kidney injury but was successfully treated with extracorporeal membrane oxygenation [<a href="#rid11">11</a>]. (See <a class="local">'Extracorporeal removal'</a> below.) </p><p class="headingAnchor" id="H12"><span class="h2">Central nervous system toxicity</span><span class="headingEndMark"> — </span>Acute central nervous system toxicity related to NSAID use is pervasive and varied. A prospective study looking at <a class="drug drug_general" data-topicid="8547" href="/d/drug information/8547.html" rel="external">ibuprofen</a> overdose noted that 30 percent of patients experienced CNS effects ranging from drowsiness to coma [<a href="#rid18">18</a>]. Case reports have identified numerous neurologic sequelae including ataxia, nystagmus, headaches, and disorientation [<a href="#rid19">19</a>].</p><p>Seizures have been reported with ingestions of propionic acids (<a class="drug drug_general" data-topicid="8547" href="/d/drug information/8547.html" rel="external">ibuprofen</a>), pyrazolones (phenylbutazone), acetic acids (<a class="drug drug_general" data-topicid="9348" href="/d/drug information/9348.html" rel="external">diclofenac</a> and <a class="drug drug_general" data-topicid="8559" href="/d/drug information/8559.html" rel="external">indomethacin</a>), and anthranilic acids (<a class="drug drug_general" data-topicid="9601" href="/d/drug information/9601.html" rel="external">mefenamic acid</a> and <a class="drug drug_general" data-topicid="9599" href="/d/drug information/9599.html" rel="external">meclofenamate</a>) [<a href="#rid20">20-25</a>]. Most cases occurred after large ingestions, but even small therapeutic doses have been associated with seizures in certain patients. The mechanism by which NSAIDs cause seizures is not clear. Some speculate that decreased cerebral prostaglandin and thromboxane synthesis may lower the seizure threshold [<a href="#rid23">23,25</a>].</p><p>Although drug-induced aseptic meningitis (DIAM) is a rare adverse CNS effect associated with NSAIDs, one case report describes its occurrence in a 29-year-old, healthy (non-atopic) woman [<a href="#rid26">26</a>]. DIAM is a type IV hypersensitivity reaction that has been reported in the past (as early as 1978), but this case is remarkable because it appears to be the first case in which dermatologic patch testing confirmed <a class="drug drug_general" data-topicid="8547" href="/d/drug information/8547.html" rel="external">ibuprofen</a> as the causative agent.</p><p class="headingAnchor" id="H13"><span class="h2">Hematologic toxicity</span><span class="headingEndMark"> — </span>Aplastic anemia and agranulocytosis have been associated with the use of phenylbutazone and <a class="drug drug_general" data-topicid="8559" href="/d/drug information/8559.html" rel="external">indomethacin</a> [<a href="#rid27">27,28</a>]. In one case of aplastic anemia, the patient presented with bleeding gums and a diffuse petechial rash after ingestion of an herbal supplement containing phenylbutazone [<a href="#rid28">28</a>]. Phenylbutazones were removed from United States markets in the 1970s, but they are still available in veterinary formulations and in other countries. Discontinuation of the drug has been shown to reverse the hematologic disturbances.</p><p>Most hematologic toxicity from NSAIDs appears to be idiosyncratic (ie, not dose dependent). However, there are case reports of severe coagulopathy following overdose. One such report describes a 58-year-old woman who ingested 26 g of <a class="drug drug_general" data-topicid="9682" href="/d/drug information/9682.html" rel="external">naproxen</a> in a suicide attempt, became critically ill, and developed severe coagulopathy [<a href="#rid29">29</a>]. The patient's serum naproxen concentration at admission was 1320 mg/L (5729 micromol/L), and on hospital day seven, coagulopathy manifested with a prothrombin time below ten percent and platelet concentration of 45 g/L. Treatment with blood products led to resolution of the coagulopathy without significant bleeding. The authors theorized that thromboxane A2 inhibition and impaired activation of clotting factors by naproxen may have caused the coagulopathy.</p><p class="headingAnchor" id="H14"><span class="h2">Allergic reactions</span><span class="headingEndMark"> — </span>NSAIDs may cause several types of allergic reactions, particularly in patients with chronic urticaria or asthma. Symptoms can range in severity from a worsening of chronic urticaria to full anaphylaxis. The management of anaphylaxis due to NSAID ingestion is the same as that of anaphylaxis from any cause. (See  <a class="medical medical_review" href="/d/html/392.html" rel="external">"Anaphylaxis: Emergency treatment"</a>.)</p><p>Patients with apparent allergic reactions to NSAID or <a class="drug drug_general" data-topicid="8907" href="/d/drug information/8907.html" rel="external">aspirin</a> should discontinue all NSAIDs until they have been specifically evaluated for this problem. (See  <a class="medical medical_review" href="/d/html/2082.html" rel="external">"NSAIDs (including aspirin): Allergic and pseudoallergic reactions"</a>.)</p><p class="headingAnchor" id="H5178851"><span class="h1">LABORATORY EVALUATION</span></p><p class="headingAnchor" id="H5178879"><span class="h2">General diagnostic testing</span><span class="headingEndMark"> — </span>Routine laboratory evaluation of the poisoned patient should include the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Fingerstick glucose, to rule out hypoglycemia as the cause of any alteration in mental status</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9242" href="/d/drug information/9242.html" rel="external">Acetaminophen</a> and salicylate levels, to rule out these common coingestions</p><p class="bulletIndent1"><span class="glyph">●</span>Electrocardiogram, to rule out conduction system poisoning by coingestants that affect the QRS or the QTc intervals</p><p class="bulletIndent1"><span class="glyph">●</span>Pregnancy test in all women of childbearing age</p><p></p><p class="headingAnchor" id="H5178886"><span class="h2">Testing for NSAID toxicity</span><span class="headingEndMark"> — </span>Although measurement of NSAID serum concentrations provides one means to assess overdose severity, such measurement has no clear role in acute management. Concentrations correlate poorly with symptoms, rarely return in a timely fashion, and are not clinically useful [<a href="#rid18">18,30</a>]. </p><p>Routine measurement of renal function (blood urea nitrogen [BUN] and serum creatinine) is not indicated in patients with minor, asymptomatic ingestions [<a href="#rid30">30</a>]. However, in symptomatic patients or those with massive ingestions, measurement of baseline renal function as well as serum electrolytes is prudent. A complete blood count to determine the hemoglobin and platelet levels is appropriate in patients with NSAID-induced bleeding. In massive ingestion (approximately &gt;400 mg/kg in a child or &gt;6 g in an adult) or when the etiology of mental status alteration is unknown, we recommend obtaining an arterial blood gas to determine acid-base status. </p><p class="headingAnchor" id="H843407073"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>Diagnosis of NSAID poisoning is made on the basis of the history. In the large majority of NSAID poisoning cases, symptoms and signs are nonspecific, and often mild. The most common signs and symptoms are nausea, vomiting, drowsiness, blurred vision, and dizziness. </p><p class="headingAnchor" id="H1193809937"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>Patients with a suspected overdose can be a challenge for even the most experienced clinician. With an unreliable patient or an unclear history, the goal of the treating clinician is to construct a broad differential and ensure critical interventions are performed in a timely manner. These management issues are reviewed in detail separately. (See  <a class="medical medical_review" href="/d/html/324.html" rel="external">"General approach to drug poisoning in adults"</a> and  <a class="medical medical_review" href="/d/html/13850.html" rel="external">"Initial management of the critically ill adult with an unknown overdose"</a>.)</p><p>Medications commonly coingested or mistaken for NSAIDs, namely salicylic acid (<a class="drug drug_general" data-topicid="8907" href="/d/drug information/8907.html" rel="external">aspirin</a>) and <a class="drug drug_general" data-topicid="9242" href="/d/drug information/9242.html" rel="external">acetaminophen</a>, should always be considered in the differential diagnosis of a patient with purported NSAID poisoning. Both aspirin and acetaminophen are potentially lethal in overdose. Initial manifestations of acetaminophen toxicity are often mild, but poisoning can be determined through serial laboratory testing using an accepted nomogram if the time of ingestion is known. Early symptoms of acute aspirin toxicity include tinnitus, vertigo, nausea and vomiting, and diarrhea; subsequent symptoms portending a more severe intoxication include altered mental status (ranging from agitation to lethargy), hyperpyrexia, noncardiac pulmonary edema, and coma. In addition to clinical signs, salicylate toxicity can be diagnosed with laboratory testing. (See  <a class="medical medical_review" href="/d/html/340.html" rel="external">"Acetaminophen (paracetamol) poisoning in adults: Pathophysiology, presentation, and evaluation"</a> and  <a class="medical medical_review" href="/d/html/318.html" rel="external">"Acetaminophen (paracetamol) poisoning: Management in adults and children"</a> and  <a class="medical medical_review" href="/d/html/329.html" rel="external">"Salicylate (aspirin) poisoning: Clinical manifestations and evaluation"</a>.)</p><p>Diagnosing a large, acute overdose of NSAIDs can be challenging in the absence of a history of the exposure. Patients presenting with altered mental status should be evaluated in a step wise manner, as is discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/5104.html" rel="external">"Stupor and coma in adults"</a> and  <a class="medical medical_review" href="/d/html/13850.html" rel="external">"Initial management of the critically ill adult with an unknown overdose"</a>.)</p><p>Complications of acute NSAID ingestion (eg, gastrointestinal bleeding, acute renal injury, seizures) may manifest without a clear history of ingestion, but these can be successfully treated with standard supportive measures. (See  <a class="medical medical_review" href="/d/html/2548.html" rel="external">"Approach to acute upper gastrointestinal bleeding in adults"</a> and  <a class="medical medical_review" href="/d/html/14035.html" rel="external">"Overview of the management of acute kidney injury (AKI) in adults"</a> and  <a class="medical medical_review" href="/d/html/96933.html" rel="external">"Convulsive status epilepticus in adults: Management"</a> and  <a class="medical medical_review" href="/d/html/2219.html" rel="external">"Evaluation and management of the first seizure in adults", section on 'Early postseizure management'</a>.)</p><p class="headingAnchor" id="H15"><span class="h1">MANAGEMENT OF ACUTE TOXICITY</span><span class="headingEndMark"> — </span>A summary table to facilitate emergent management is provided (<a class="graphic graphic_table graphicRef59428" href="/d/graphic/59428.html" rel="external">table 1</a>). </p><p class="headingAnchor" id="H16"><span class="h2">Airway, breathing, circulation</span><span class="headingEndMark"> — </span>As with any poisoned patient, the clinician's first responsibility is to secure the airway, breathing, and circulation. However, apnea and hypotension are rare so aggressive intervention is usually unnecessary. In the unusual circumstance where intubation and mechanical ventilation are necessary, it is important to adjust the ventilator appropriately to help compensate for any underlying acidosis. (See  <a class="medical medical_review" href="/d/html/267.html" rel="external">"Basic airway management in adults"</a> and  <a class="medical medical_review" href="/d/html/276.html" rel="external">"Overview of advanced airway management in adults for emergency medicine and critical care"</a> and  <a class="medical medical_review" href="/d/html/277.html" rel="external">"Mechanical ventilation of adults in the emergency department"</a>.)</p><p class="headingAnchor" id="H17"><span class="h2">Gastrointestinal decontamination</span><span class="headingEndMark"> — </span>We suggest gastrointestinal decontamination with activated charcoal (AC) for patients with acute NSAID ingestion who present within two hours of ingestion, unless specific contraindications exist (bowel obstruction, perforation, etc). Aspiration risk, including mental status and the ability to protect the airway, must be assessed in all patients before any attempts to administer AC. </p><p>Multiple doses of AC (MDAC) are thought to be ineffective in acute NSAID ingestion because of the low enterohepatic recirculation and high protein binding of the majority of these drugs. Although certain NSAIDs have increased enterohepatic circulation (eg, <a class="drug drug_general" data-topicid="9682" href="/d/drug information/9682.html" rel="external">naproxen</a>, <a class="drug drug_general" data-topicid="9671" href="/d/drug information/9671.html" rel="external">nabumetone</a>, <a class="drug drug_general" data-topicid="9967" href="/d/drug information/9967.html" rel="external">sulindac</a>, and <a class="drug drug_general" data-topicid="9781" href="/d/drug information/9781.html" rel="external">piroxicam</a>), no clinical studies have demonstrated a benefit from MDAC, and the American Academy of Clinical Toxicology does not recommend its use in the treatment of NSAID overdose [<a href="#rid31">31</a>]. However, MDAC may be useful in patients with a massive overdose of a sustained release NSAID. In such cases, consultation with a medical toxicologist or regional poison control center is prudent. (See <a class="local">'Additional resources'</a> below.)</p><p class="headingAnchor" id="H18"><span class="h2">Other supportive measures</span><span class="headingEndMark"> — </span>Supportive treatment is indicated for correction of metabolic acidosis after NSAID ingestion. The appropriate role of early volume correction and bicarbonate administration is debated [<a href="#rid7">7,30,32-42</a>]. Although we suggest the early use of crystalloid to correct volume depletion, we do not suggest routine use of bicarbonate therapy because of the lack of data demonstrating efficacy. Multiple case reports describe bicarbonate infusion as a temporizing measure for severe acidosis following massive NSAID ingestion. However, given the lack of evidence supporting this therapy, we recommend consultation with a poison control center or medical toxicologist before initiating treatment [<a href="#rid8">8,10</a>]. (See  <a class="medical medical_review" href="/d/html/2294.html" rel="external">"Bicarbonate therapy in lactic acidosis"</a>.)</p><p>Seizures are treated in standard fashion with benzodiazepines. Hypothermia generally responds to active external warming (eg, heating blanket). (See  <a class="medical medical_review" href="/d/html/178.html" rel="external">"Accidental hypothermia in adults", section on 'Management'</a> and  <a class="medical medical_review" href="/d/html/96933.html" rel="external">"Convulsive status epilepticus in adults: Management", section on 'Emergency antiseizure treatment'</a>.) </p><p class="headingAnchor" id="H19"><span class="h2">Antidote</span><span class="headingEndMark"> — </span>There are no antidotes for NSAID toxicity.</p><p class="headingAnchor" id="H20"><span class="h2">Extracorporeal removal</span><span class="headingEndMark"> — </span>Extracorporeal removal of NSAIDs via hemodialysis is ineffective due to the high degree of protein binding characteristic of all NSAIDs. One case report describes the efficacious use of plasmapheresis in a 15-year-old female with acute phenylbutazone toxicity, and another report describes extracorporeal membrane oxygenation (ECMO) in a 14-year-old male with massive <a class="drug drug_general" data-topicid="8547" href="/d/drug information/8547.html" rel="external">ibuprofen</a> ingestion. However, such invasive measures are not recommended or necessary in most cases [<a href="#rid11">11,43,44</a>]. We recommend consultation with a regional poison control center or medical toxicologist to determine if such therapeutic techniques are warranted, as may be the case in patients with severe metabolic acidosis or acute kidney injury. (See <a class="local">'Additional resources'</a> below.) </p><p class="headingAnchor" id="H21"><span class="h2">Patient disposition</span><span class="headingEndMark"> — </span>Patients with ingestions under 100 mg/kg (excluding <a class="drug drug_general" data-topicid="9601" href="/d/drug information/9601.html" rel="external">mefenamic acid</a> and phenylbutazone) who are asymptomatic and not suicidal may be safely discharged following any needed supportive measures (gastrointestinal decontamination, hydration, etc.) and a four to six-hour period of observation, depending upon the agent ingested. Drugs with a longer half-life (eg, <a class="drug drug_general" data-topicid="9682" href="/d/drug information/9682.html" rel="external">Naproxen</a>) require longer observation. (See <a class="local">'Kinetics'</a> above.)</p><p>Suicidal patients, patients who manifest signs of severe intoxication (eg, pH &lt;7.3, acute renal dysfunction, altered mental status), and those with other medical or psychosocial concerns should be admitted. As with all poisonings, determination of coingestions (eg, <a class="drug drug_general" data-topicid="9242" href="/d/drug information/9242.html" rel="external">acetaminophen</a>, <a class="drug drug_general" data-topicid="8907" href="/d/drug information/8907.html" rel="external">aspirin</a>) is important and will affect disposition.</p><p>Although there are little data regarding mefenamic acid and phenylbutazone ingestions, we recommend 24-hour observation in such cases because of the risk of seizures in the former and multiple potential complications in the latter [<a href="#rid20">20-22,27</a>].</p><p class="headingAnchor" id="H22"><span class="h1">CHRONIC TOXICITY</span><span class="headingEndMark"> — </span>Most toxicity related to NSAIDs occurs after chronic use. An overview of chronic toxicity, including references to detailed discussions of specific toxicities, is provided elsewhere. (See  <a class="medical medical_review" href="/d/html/7991.html" rel="external">"Nonselective NSAIDs: Overview of adverse effects"</a>.)</p><p class="headingAnchor" id="H1283690547"><span class="h1">SPECIAL POPULATIONS</span></p><p class="headingAnchor" id="H3710894779"><span class="h2">Pediatrics</span><span class="headingEndMark"> — </span>NSAIDs are commonly ingested by children and adolescents, and <a class="drug drug_general" data-topicid="8547" href="/d/drug information/8547.html" rel="external">ibuprofen</a> is the most commonly ingested NSAID [<a href="#rid45">45</a>]. For most NSAIDs (except <a class="drug drug_general" data-topicid="9601" href="/d/drug information/9601.html" rel="external">mefenamic acid</a> and phenylbutazone), when symptoms do occur, the onset is within four hours of ingestion and includes nausea, vomiting, abdominal pain, headache, drowsiness, blurred vision, tinnitus, ataxia, and dizziness [<a href="#rid6">6,41</a>]. Life-threatening toxicity is rare; can include coma, metabolic acidosis, apnea, and cardiovascular collapse; and occurs at ingested doses ≥400 mg/kg [<a href="#rid11">11,36,37</a>]. Young children (≤5 years old) are more likely to have exploratory, low-dose ingestions as compared with adolescents or adults, who are more likely to have intentional ingestions.</p><p>Assessment and management of children and adolescents with NSAID poisoning is similar to adults and generally supportive. Children who ingest an NSAID (except <a class="drug drug_general" data-topicid="9601" href="/d/drug information/9601.html" rel="external">mefenamic acid</a> and phenylbutazone) at a dose &lt;200 mg/kg and who have either mild symptoms (eg, nausea, vomiting, or abdominal pain) that resolve or are asymptomatic do <strong>not</strong> need routine laboratory studies. If the ingestion was intentional or the formulation of the NSAID is unclear, <a class="drug drug_general" data-topicid="9242" href="/d/drug information/9242.html" rel="external">acetaminophen</a> and salicylate concentrations should be checked to rule out these common co-ingestants.</p><p>Home management of young children with exploratory ingestions of NSAIDs is frequently feasible as long as they remain asymptomatic, the formulation and maximum ingested dose is certain, and the caretaker is reliable. Consultation with a regional poison control center is frequently helpful in making this decision and should be undertaken if there is any uncertainty about the safety of home management. Regional poison control centers often suggest home monitoring and management of asymptomatic poisoned patients in whom toxicity is unlikely. (See <a class="local">'Regional poison control centers'</a> below.)</p><p class="headingAnchor" id="H23"><span class="h1">ADDITIONAL RESOURCES</span></p><p class="headingAnchor" id="H1155572804"><span class="h2">Regional poison control centers</span><span class="headingEndMark"> — </span>Regional poison control centers in the United States are available at all times for consultation on patients with known or suspected poisoning, and who may be critically ill, require admission, or have clinical pictures that are unclear (1-800-222-1222). In addition, some hospitals have medical toxicologists available for bedside consultation. Whenever available, these are invaluable resources to help in the diagnosis and management of ingestions or overdoses. Contact information for poison centers around the world is provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/138307.html" rel="external">"Society guideline links: Regional poison control centers"</a>.)</p><p class="headingAnchor" id="H2474162291"><span class="h2">Society guideline links</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/112689.html" rel="external">"Society guideline links: General measures for acute poisoning treatment"</a>.)</p><p class="headingAnchor" id="H1728639"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, “The Basics” and “Beyond the Basics.” The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/d/html/16268.html" rel="external">"Patient education: Nonsteroidal antiinflammatory drugs (NSAIDs) (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topic (see  <a class="medical medical_patient" href="/d/html/519.html" rel="external">"Patient education: Nonsteroidal antiinflammatory drugs (NSAIDs) (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H24"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Overview</strong> – Nonsteroidal antiinflammatory drugs (NSAIDs) are among the most common classes of medications prescribed. Despite high rates of acute NSAID overdose, few patients experience poor outcomes, and most require no medical intervention or supportive care alone. A summary table to facilitate emergency management is provided (<a class="graphic graphic_table graphicRef59428" href="/d/graphic/59428.html" rel="external">table 1</a>). (See <a class="local">'Introduction'</a> above and <a class="local">'General'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>History</strong> – Patients should be specifically questioned about their use of <a class="drug drug_general" data-topicid="9242" href="/d/drug information/9242.html" rel="external">acetaminophen</a> and <a class="drug drug_general" data-topicid="8907" href="/d/drug information/8907.html" rel="external">aspirin</a>, as these are commonly mistaken for NSAIDs but can cause severe toxicity and may be life-threatening in overdose. (See <a class="local">'History and physical examination'</a> above and  <a class="medical medical_review" href="/d/html/340.html" rel="external">"Acetaminophen (paracetamol) poisoning in adults: Pathophysiology, presentation, and evaluation"</a> and  <a class="medical medical_review" href="/d/html/329.html" rel="external">"Salicylate (aspirin) poisoning: Clinical manifestations and evaluation"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Toxic and nontoxic doses</strong> – NSAID (except <a class="drug drug_general" data-topicid="9601" href="/d/drug information/9601.html" rel="external">mefenamic acid</a> and phenylbutazone) ingestions of less than 100 mg/kg are unlikely to cause significant symptoms in adults. Ingestions greater than approximately 400 mg/kg (lean body weight) can cause severe symptoms. (See <a class="local">'General'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical features of acute toxicity</strong> – Symptoms and examination findings in NSAID intoxication are generally nonspecific. The most common signs and symptoms are nausea, vomiting, drowsiness, blurred vision, and dizziness. (See <a class="local">'General'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Increased anion gap metabolic acidosis</strong> – This may be seen after large ingestions, particularly those involving <a class="drug drug_general" data-topicid="8547" href="/d/drug information/8547.html" rel="external">ibuprofen</a>, <a class="drug drug_general" data-topicid="9682" href="/d/drug information/9682.html" rel="external">naproxen</a>, and phenylbutazone. (See <a class="local">'Acid base abnormalities'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Kidney injury and renal papillary necrosis</strong> – These are rare and occur most often in patients with decreased effective arterial volume, age-related underlying renal dysfunction, or massive overdose. (See <a class="local">'Acute kidney injury'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Acute central nervous system toxicity</strong> – Clinical manifestations are varied, ranging from drowsiness to seizure to coma. (See <a class="local">'Central nervous system toxicity'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Anaphylactic and anaphylactoid reactions</strong> – These can occur particularly in patients with chronic urticaria or asthma. (See <a class="local">'Allergic reactions'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Laboratory evaluation</strong> – <a class="drug drug_general" data-topicid="9242" href="/d/drug information/9242.html" rel="external">Acetaminophen</a> and salicylate serum concentrations should be obtained in all patients with suspected NSAID poisoning. In symptomatic patients and those with large ingestions, tests of renal function (blood urea nitrogen [BUN], serum creatinine), serum electrolytes, and an arterial blood gas should be obtained. In bleeding patients, hemoglobin and platelet counts should be measured. NSAID serum concentrations are generally not helpful. (See <a class="local">'Laboratory evaluation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management</strong> – In patients with NSAID overdose, the clinician's first responsibility is to secure the airway, breathing, and circulation. Aggressive intervention is usually unnecessary. No antidote exists. Extracorporeal removal is ineffective. (See <a class="local">'Management of acute toxicity'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Gastrointestinal decontamination</strong> – In patients who present within two hours of an acute ingestion, we suggest gastrointestinal decontamination with activated charcoal (AC) (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). Aspiration risk should be assessed in all patients before any attempts to administer AC. (See <a class="local">'Gastrointestinal decontamination'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Disposition</strong> – Patients with minor ingestions who are asymptomatic and not suicidal may be discharged safely after a four- to six-hour period of observation, depending upon the agent ingested. Suicidal patients, patients who manifest signs of severe intoxication (eg, pH &lt;7.3, acute renal dysfunction, altered mental status), and those with other medical or psychosocial concerns should be admitted. (See <a class="local">'Patient disposition'</a> above.)</p><p></p><p class="bulletIndent1">Observe patients for 24 hours in cases of the following NSAID ingestions (see <a class="local">'Management of acute toxicity'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Mefenamic acid – Risk of seizures</p><p class="bulletIndent2"><span class="glyph">•</span>Phenylbutazone – Risk of seizures, metabolic acidosis, aplastic anemia, and agranulocytosis</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Bronstein AC, Spyker DA, Cantilena LR Jr, et al. 2008 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 26th Annual Report. Clin Toxicol (Phila) 2009; 47:911.</a></li><li><a class="nounderline abstract_t">Parente L, Perretti M. Advances in the pathophysiology of constitutive and inducible cyclooxygenases: two enzymes in the spotlight. Biochem Pharmacol 2003; 65:153.</a></li><li><a class="nounderline abstract_t">Wallace JL, Bak A, McKnight W, et al. Cyclooxygenase 1 contributes to inflammatory responses in rats and mice: implications for gastrointestinal toxicity. Gastroenterology 1998; 115:101.</a></li><li><a class="nounderline abstract_t">Ochi T, Goto T. Differential effect of FR122047, a selective cyclo-oxygenase-1 inhibitor, in rat chronic models of arthritis. Br J Pharmacol 2002; 135:782.</a></li><li class="breakAll">Goldfrank LR, Flomenbaum NE, Lewin NA, et al. Goldfrank's Toxicologic Emergencies, 7th, McGraw-Hill, New York 2002.</li><li><a class="nounderline abstract_t">Smolinske SC, Hall AH, Vandenberg SA, et al. Toxic effects of nonsteroidal anti-inflammatory drugs in overdose. An overview of recent evidence on clinical effects and dose-response relationships. Drug Saf 1990; 5:252.</a></li><li><a class="nounderline abstract_t">Volans G, Monaghan J, Colbridge M. Ibuprofen overdose. Int J Clin Pract Suppl 2003; :54.</a></li><li><a class="nounderline abstract_t">Holubek W, Stolbach A, Nurok S, et al. A report of two deaths from massive ibuprofen ingestion. J Med Toxicol 2007; 3:52.</a></li><li><a class="nounderline abstract_t">Desai PR, Sriskandan S. Hypothermia in a child secondary to ibuprofen. Arch Dis Child 2003; 88:87.</a></li><li><a class="nounderline abstract_t">Wood DM, Monaghan J, Streete P, et al. Fatality after deliberate ingestion of sustained-release ibuprofen: a case report. Crit Care 2006; 10:R44.</a></li><li><a class="nounderline abstract_t">Marciniak KE, Thomas IH, Brogan TV, et al. Massive ibuprofen overdose requiring extracorporeal membrane oxygenation for cardiovascular support. Pediatr Crit Care Med 2007; 8:180.</a></li><li><a class="nounderline abstract_t">Levine M, Khurana A, Ruha AM. Polyuria, acidosis, and coma following massive ibuprofen ingestion. J Med Toxicol 2010; 6:315.</a></li><li><a class="nounderline abstract_t">Gambaro G, Perazella MA. Adverse renal effects of anti-inflammatory agents: evaluation of selective and nonselective cyclooxygenase inhibitors. J Intern Med 2003; 253:643.</a></li><li><a class="nounderline abstract_t">Griffin MR, Yared A, Ray WA. Nonsteroidal antiinflammatory drugs and acute renal failure in elderly persons. Am J Epidemiol 2000; 151:488.</a></li><li><a class="nounderline abstract_t">Whelton A, Schulman G, Wallemark C, et al. Effects of celecoxib and naproxen on renal function in the elderly. Arch Intern Med 2000; 160:1465.</a></li><li><a class="nounderline abstract_t">Whelton A. Renal and related cardiovascular effects of conventional and COX-2-specific NSAIDs and non-NSAID analgesics. Am J Ther 2000; 7:63.</a></li><li><a class="nounderline abstract_t">Murray MD, Brater DC. Renal toxicity of the nonsteroidal anti-inflammatory drugs. Annu Rev Pharmacol Toxicol 1993; 33:435.</a></li><li><a class="nounderline abstract_t">McElwee NE, Veltri JC, Bradford DC, Rollins DE. A prospective, population-based study of acute ibuprofen overdose: complications are rare and routine serum levels not warranted. Ann Emerg Med 1990; 19:657.</a></li><li><a class="nounderline abstract_t">Vale JA, Meredith TJ. Acute poisoning due to non-steroidal anti-inflammatory drugs. Clinical features and management. Med Toxicol 1986; 1:12.</a></li><li><a class="nounderline abstract_t">Robson RH, Balali M, Critchley J, et al. Mefenamic acid poisoning and epilepsy. Br Med J 1979; 2:1438.</a></li><li><a class="nounderline abstract_t">Balali-Mood M, Critchley JA, Proudfoot AT, Prescott LF. Mefenamic acid overdosage. Lancet 1981; 1:1354.</a></li><li><a class="nounderline abstract_t">Kingswell RS. Mefenamic acid overdose. Lancet 1981; 2:307.</a></li><li><a class="nounderline abstract_t">Steinhauer HB, Hertting G. Lowering of the convulsive threshold by non-steroidal anti-inflammatory drugs. Eur J Pharmacol 1981; 69:199.</a></li><li><a class="nounderline abstract_t">Frank JJ, Wightkin WT, Hubner JW. Acute toxicity of nonsteroidal antiinflammatory agents: seizure following a mefenamic acid overdose. Drug Intell Clin Pharm 1983; 17:204.</a></li><li><a class="nounderline abstract_t">Sánchez-Hernandez MC, Delgado J, Navarro AM, et al. Seizures induced by NSAID. Allergy 1999; 54:90.</a></li><li><a class="nounderline abstract_t">Bianchi L, Marietti R, Hansel K, et al. Drug-induced aseptic meningitis to ibuprofen: The first case confirmed by positive patch test. Contact Dermatitis 2020; 82:405.</a></li><li><a class="nounderline abstract_t">Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. The International Agranulocytosis and Aplastic Anemia Study. JAMA 1986; 256:1749.</a></li><li><a class="nounderline abstract_t">Nelson L, Shih R, Hoffman R. Aplastic anemia induced by an adulterated herbal medication. J Toxicol Clin Toxicol 1995; 33:467.</a></li><li><a class="nounderline abstract_t">Lelièvre B, Drouillard I, Thill C, et al. Severe poisoning with naproxen causing coagulopathy. Basic Clin Pharmacol Toxicol 2020; 126:458.</a></li><li><a class="nounderline abstract_t">Hall AH, Smolinske SC, Stover B, et al. Ibuprofen overdose in adults. J Toxicol Clin Toxicol 1992; 30:23.</a></li><li><a class="nounderline abstract_t">Position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol 1999; 37:731.</a></li><li><a class="nounderline abstract_t">Court H, Volans GN. Poisoning after overdose with non-steroidal anti-inflammatory drugs. Adverse Drug React Acute Poisoning Rev 1984; 3:1.</a></li><li><a class="nounderline abstract_t">Martinez R, Smith DW, Frankel LR. Severe metabolic acidosis after acute naproxen sodium ingestion. Ann Emerg Med 1989; 18:1102.</a></li><li><a class="nounderline abstract_t">Le HT, Bosse GM, Tsai Y. Ibuprofen overdose complicated by renal failure, adult respiratory distress syndrome, and metabolic acidosis. J Toxicol Clin Toxicol 1994; 32:315.</a></li><li><a class="nounderline abstract_t">Seifert SA, Bronstein AC, McGuire T. Massive ibuprofen ingestion with survival. J Toxicol Clin Toxicol 2000; 38:55.</a></li><li><a class="nounderline abstract_t">Oker EE, Hermann L, Baum CR, et al. Serious toxicity in a young child due to ibuprofen. Acad Emerg Med 2000; 7:821.</a></li><li><a class="nounderline abstract_t">Zuckerman GB, Uy CC. Shock, metabolic acidosis, and coma following ibuprofen overdose in a child. Ann Pharmacother 1995; 29:869.</a></li><li><a class="nounderline abstract_t">Downie A, Ali A, Bell D. Severe metabolic acidosis complicating massive ibuprofen overdose. Postgrad Med J 1993; 69:575.</a></li><li><a class="nounderline abstract_t">Hall AH, Smolinske SC, Kulig KW, Rumack BH. Ibuprofen overdose--a prospective study. West J Med 1988; 148:653.</a></li><li><a class="nounderline abstract_t">Lee CY, Finkler A. Acute intoxication due to ibuprofen overdose. Arch Pathol Lab Med 1986; 110:747.</a></li><li><a class="nounderline abstract_t">Hall AH, Smolinske SC, Conrad FL, et al. Ibuprofen overdose: 126 cases. Ann Emerg Med 1986; 15:1308.</a></li><li><a class="nounderline abstract_t">Court H, Streete P, Volans GN. Acute poisoning with ibuprofen. Hum Toxicol 1983; 2:381.</a></li><li><a class="nounderline abstract_t">Virji MA, Venkataraman ST, Lower DR, Rao KN. Role of laboratory in the management of phenylbutazone poisoning. J Toxicol Clin Toxicol 2003; 41:1013.</a></li><li><a class="nounderline abstract_t">Geith S, Renner B, Rabe C, et al. Ibuprofen plasma concentration profile in deliberate ibuprofen overdose with circulatory depression treated with therapeutic plasma exchange: a case report. BMC Pharmacol Toxicol 2017; 18:81.</a></li><li><a class="nounderline abstract_t">Gummin DD, Mowry JB, Beuhler MC, et al. 2019 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 37th Annual Report. Clin Toxicol (Phila) 2020; 58:1360.</a></li></ol></div><div id="topicVersionRevision">Topic 341 Version 23.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20028214" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : 2008 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 26th Annual Report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12504791" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Advances in the pathophysiology of constitutive and inducible cyclooxygenases: two enzymes in the spotlight.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9649464" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Cyclooxygenase 1 contributes to inflammatory responses in rats and mice: implications for gastrointestinal toxicity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11834626" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Differential effect of FR122047, a selective cyclo-oxygenase-1 inhibitor, in rat chronic models of arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11834626" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Differential effect of FR122047, a selective cyclo-oxygenase-1 inhibitor, in rat chronic models of arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2198051" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Toxic effects of nonsteroidal anti-inflammatory drugs in overdose. An overview of recent evidence on clinical effects and dose-response relationships.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12723749" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Ibuprofen overdose.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18072160" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : A report of two deaths from massive ibuprofen ingestion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12495977" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Hypothermia in a child secondary to ibuprofen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16542487" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Fatality after deliberate ingestion of sustained-release ibuprofen: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17273120" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Massive ibuprofen overdose requiring extracorporeal membrane oxygenation for cardiovascular support.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20419362" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Polyuria, acidosis, and coma following massive ibuprofen ingestion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12755960" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Adverse renal effects of anti-inflammatory agents: evaluation of selective and nonselective cyclooxygenase inhibitors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10707917" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Nonsteroidal antiinflammatory drugs and acute renal failure in elderly persons.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10826459" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Effects of celecoxib and naproxen on renal function in the elderly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11319575" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Renal and related cardiovascular effects of conventional and COX-2-specific NSAIDs and non-NSAID analgesics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8494347" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Renal toxicity of the nonsteroidal anti-inflammatory drugs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2188537" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : A prospective, population-based study of acute ibuprofen overdose: complications are rare and routine serum levels not warranted.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3537613" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Acute poisoning due to non-steroidal anti-inflammatory drugs. Clinical features and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/519499" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Mefenamic acid poisoning and epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6113321" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Mefenamic acid overdosage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6114349" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Mefenamic acid overdose.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7202518" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Lowering of the convulsive threshold by non-steroidal anti-inflammatory drugs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6839946" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Acute toxicity of nonsteroidal antiinflammatory agents: seizure following a mefenamic acid overdose.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10195372" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Seizures induced by NSAID.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32034786" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Drug-induced aseptic meningitis to ibuprofen: The first case confirmed by positive patch test.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3747087" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. The International Agranulocytosis and Aplastic Anemia Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7650772" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Aplastic anemia induced by an adulterated herbal medication.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31742906" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Severe poisoning with naproxen causing coagulopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1542147" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Ibuprofen overdose in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10584586" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6541425" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Poisoning after overdose with non-steroidal anti-inflammatory drugs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2552870" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Severe metabolic acidosis after acute naproxen sodium ingestion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8007040" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Ibuprofen overdose complicated by renal failure, adult respiratory distress syndrome, and metabolic acidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10696926" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Massive ibuprofen ingestion with survival.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10917334" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Serious toxicity in a young child due to ibuprofen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8547735" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Shock, metabolic acidosis, and coma following ibuprofen overdose in a child.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8415347" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Severe metabolic acidosis complicating massive ibuprofen overdose.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3176471" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Ibuprofen overdose--a prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3755329" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Acute intoxication due to ibuprofen overdose.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3777588" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Ibuprofen overdose: 126 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6862484" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Acute poisoning with ibuprofen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14705852" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Role of laboratory in the management of phenylbutazone poisoning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29233194" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Ibuprofen plasma concentration profile in deliberate ibuprofen overdose with circulatory depression treated with therapeutic plasma exchange: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33305966" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : 2019 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 37th Annual Report.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
